Dr. Stephanie Gaillard is an Assistant Professor in Medical Oncology at the Duke Cancer Institute. She pursued her undergraduate training at the University of Virginia where she earned a Bachelor of Science in Chemistry with highest distinction. Prior to enrolling in medical school, she worked with Kathleen Rundell at Northwestern University studying cell cycle regulation. During her medical and graduate training at Duke University, she studied the role of Estrogen Receptor-Related Receptors in the regulation of metabolism in cancer cells with Dr. Donald McDonnell. She went on to pursue clinical training in Internal Medicine and Medical Oncology at the Johns Hopkins Hospital, where she studied mechanisms that cause resistance to chemotherapy in ovarian cancer cells with Dr. Ie-Ming Shih. Dr. Gaillard is board certified by the American Board of Internal Medicine in both Internal Medicine and Medical Oncology. At Duke, she focuses on treating patients with gynecologic malignancies and conducts basic science and clinical research. Dr. Gaillard’s laboratory research focuses on elucidating the biology of ovarian cancer, especially metabolic changes in the development of ovarian tumors, and mechanisms of resistance to chemotherapy. Her clinical research interests center on the development of novel therapeutic strategies for the treatment of ovarian cancer. In addition to the Ovarian Cancer Research Fund Liz Tilberis Grant, Dr. Gaillard has received a Department of Defense Breast Cancer Research Program pre-doctoral research award and a Conquer Cancer Foundation Young Investigator Award.